Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX2DJB
|
||||
| Drug Name |
4-Methyl-2-(3-pyridin-2-yl-phenyl)-pentanoic acid cyanomethyl-amide
|
||||
| Synonyms |
CHEMBL122424
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C19H21N3O
|
||||
| Canonical SMILES |
CC(C)CC(C(=O)NCC#N)c1cccc(c1)c2ccccn2
|
||||
| InChI |
InChI=1S/C19H21N3O/c1-14(2)12-17(19(23)22-11-9-20)15-6-5-7-16(13-15)18-8-3-4-10-21-18/h3-8,10,13-14,17H,11-12H2,1-2H3,(H,22,23)
|
||||
| InChIKey |
ZATAGZNEJFFRSY-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.